| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6070311 | Journal of the American Academy of Dermatology | 2015 | 7 Pages |
Abstract
Keratinocyte dystrophy may help to diagnose skin toxicity of low-dose methotrexate, even in the absence of known risk factors or methotrexate administration errors. Studies of the diagnostic performance of this histologic sign are needed.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Julie MD, Nicolas MD, PhD, Emmanuel MD, Julien MD, Pierre MD, PhD, Emilie MD, PhD, Olivier MD, PhD,